| | | | | |
ADAG Adagene Inc. American Depositary Shares | $3,8800 | -0,26% | $276,84M | $6,52K | |
LCTX Lineage Cell Therapeutics, Inc. | $1,1400 | +1,79% | $276,72M | $674,00 | |
OSUR OraSure Technologies Inc | $3,8850 | +0,13% | $275,39M | $1,08K | |
| $11,0300 | +0,00% | $274,98M | $59,76K | |
NHIV NewHold Investment Corp IV Class A Ordinary Shares | $10,1250 | -0,34% | $274,74M | $11,00 | |
| $10,8201 | +0,00% | $274,40M | $18,08K | |
HVII Hennessy Capital Investment Corp. VII Ordinary Shares | $10,5250 | -0,05% | $273,50M | $16,21K | |
XSLL Xsolla SPAC 1 Class A Ordinary Shares | $9,9650 | -0,05% | $273,47M | $8,08K | |
EOT EATON VANCE NATIONAL MUNICIPAL OPPORTUNITIES TRUST | $17,5350 | +0,00% | $273,43M | $18,39K | |
DUOT Duos Technologies Group, Inc. Common Stock | $8,7700 | +0,00% | $272,98M | $1,43K | |
| $20,0500 | +0,00% | $272,90M | $3,74K | |
ZH Zhihu Inc. American Depositary Shares, each representing three (3) Class A Ordinary Shares | $3,2100 | -2,73% | $272,52M | $19,00 | |
EBS Emergent Biosolutions, Inc. | $4,4923 | +0,95% | $272,26M | $1,69K | |
SABS SAB Biotherapeutics, Inc. Common Stock | $3,7600 | +0,00% | $272,21M | $131,00 | |
FRD Friedman Industries Inc. Common Stock | $42,6100 | -0,61% | $272,06M | $169,00 | |
